Functional interleukin 2 receptors on B cells lacking Tac antigens. 1987

T Tanaka, and O Saiki, and S Doi, and M Hatakeyama, and T Doi, and T Kono, and H Mori, and M Fujii, and K Sugamura, and S Negoro
Third Department of Internal Medicine, Osaka University, Japan.

Human B lymphoblastoid line, SKW 6-4, cells were induced to IgM-secreting cells by high concentrations of interleukin 2 (IL 2). These cells were found to be unreactive with anti-Tac antibody and did not express mRNA detectable for Tac antigen. In Scatchard plot analysis, low-affinity IL 2-binding sites were found on SKW 6-4 cells. Moreover, analysis of the IL 2-binding molecules revealed ones (molecular weight 70,000 and 75,000) distinct from Tac antigen. It is conceivable that IL 2 exerts its effect through its interaction with these novel IL 2-binding molecules in SKW 6-4 cells.

UI MeSH Term Description Entries
D007075 Immunoglobulin M A class of immunoglobulin bearing mu chains (IMMUNOGLOBULIN MU-CHAINS). IgM can fix COMPLEMENT. The name comes from its high molecular weight and originally was called a macroglobulin. Gamma Globulin, 19S,IgM,IgM Antibody,IgM1,IgM2,19S Gamma Globulin,Antibody, IgM
D007376 Interleukin-2 A soluble substance elaborated by antigen- or mitogen-stimulated T-LYMPHOCYTES which induces DNA synthesis in naive lymphocytes. IL-2,Lymphocyte Mitogenic Factor,T-Cell Growth Factor,TCGF,IL2,Interleukin II,Interleukine 2,RU 49637,RU-49637,Ro-23-6019,Ro-236019,T-Cell Stimulating Factor,Thymocyte Stimulating Factor,Interleukin 2,Mitogenic Factor, Lymphocyte,RU49637,Ro 23 6019,Ro 236019,Ro236019,T Cell Growth Factor,T Cell Stimulating Factor
D011971 Receptors, Immunologic Cell surface molecules on cells of the immune system that specifically bind surface molecules or messenger molecules and trigger changes in the behavior of cells. Although these receptors were first identified in the immune system, many have important functions elsewhere. Immunologic Receptors,Immunologic Receptor,Immunological Receptors,Receptor, Immunologic,Receptors, Immunological
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000954 Antigens, Surface Antigens on surfaces of cells, including infectious or foreign cells or viruses. They are usually protein-containing groups on cell membranes or walls and may be isolated. Cell Surface Antigens,Surface Antigens,Surface Markers, Immunological,Cell Surface Antigen,Immunologic Surface Markers,Markers, Immunological Surface,Surface Antigen,Surface Markers, Immunologic,Antigen, Cell Surface,Antigen, Surface,Antigens, Cell Surface,Immunological Surface Markers,Markers, Immunologic Surface,Surface Antigen, Cell,Surface Antigens, Cell
D001402 B-Lymphocytes Lymphoid cells concerned with humoral immunity. They are short-lived cells resembling bursa-derived lymphocytes of birds in their production of immunoglobulin upon appropriate stimulation. B-Cells, Lymphocyte,B-Lymphocyte,Bursa-Dependent Lymphocytes,B Cells, Lymphocyte,B Lymphocyte,B Lymphocytes,B-Cell, Lymphocyte,Bursa Dependent Lymphocytes,Bursa-Dependent Lymphocyte,Lymphocyte B-Cell,Lymphocyte B-Cells,Lymphocyte, Bursa-Dependent,Lymphocytes, Bursa-Dependent
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated

Related Publications

T Tanaka, and O Saiki, and S Doi, and M Hatakeyama, and T Doi, and T Kono, and H Mori, and M Fujii, and K Sugamura, and S Negoro
August 1988, Blood,
T Tanaka, and O Saiki, and S Doi, and M Hatakeyama, and T Doi, and T Kono, and H Mori, and M Fujii, and K Sugamura, and S Negoro
January 1988, Nature,
T Tanaka, and O Saiki, and S Doi, and M Hatakeyama, and T Doi, and T Kono, and H Mori, and M Fujii, and K Sugamura, and S Negoro
July 1993, The Journal of clinical investigation,
T Tanaka, and O Saiki, and S Doi, and M Hatakeyama, and T Doi, and T Kono, and H Mori, and M Fujii, and K Sugamura, and S Negoro
January 1984, Current topics in microbiology and immunology,
T Tanaka, and O Saiki, and S Doi, and M Hatakeyama, and T Doi, and T Kono, and H Mori, and M Fujii, and K Sugamura, and S Negoro
November 1984, The Journal of experimental medicine,
T Tanaka, and O Saiki, and S Doi, and M Hatakeyama, and T Doi, and T Kono, and H Mori, and M Fujii, and K Sugamura, and S Negoro
October 1987, Blood,
T Tanaka, and O Saiki, and S Doi, and M Hatakeyama, and T Doi, and T Kono, and H Mori, and M Fujii, and K Sugamura, and S Negoro
January 1993, Leukemia research,
T Tanaka, and O Saiki, and S Doi, and M Hatakeyama, and T Doi, and T Kono, and H Mori, and M Fujii, and K Sugamura, and S Negoro
January 1985, The Journal of experimental medicine,
T Tanaka, and O Saiki, and S Doi, and M Hatakeyama, and T Doi, and T Kono, and H Mori, and M Fujii, and K Sugamura, and S Negoro
October 1987, Clinical and experimental immunology,
T Tanaka, and O Saiki, and S Doi, and M Hatakeyama, and T Doi, and T Kono, and H Mori, and M Fujii, and K Sugamura, and S Negoro
December 1992, Journal of immunology (Baltimore, Md. : 1950),
Copied contents to your clipboard!